Perennial Allergic Rhinitis
📧 Sign up to get email alerts when something new happens for Perennial Allergic Rhinitis.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2026-04-20Clinical Trial Update: A Study of Lebrikizumab in Adult Participants With Perennial Allergic Rhinitis (PREPARED-1) [Phase 3]
A Phase 3 clinical trial evaluating Lebrikizumab in adults with perennial allergic rhinitis is currently recruiting.
-
CLINICAL_TRIALS research · 2026-03-09Clinical Trial Update: Trial of JYB1904 Injection in Patients With Perennial Allergic Rhinitis [Phase 2]
A Phase 2 clinical trial evaluating JYB1904 Injection for perennial allergic rhinitis is not yet recruiting.
-
EMA approval · 2026-03-02EMA Authorised: Azomyr (desloratadine) — Organon N.V.
The European Medicines Agency authorised Azomyr, a desloratadine-containing medicine by Organon N.V., for allergic rhinitis (seasonal and pe…
-
CLINICAL_TRIALS research · 2025-11-24Clinical Trial Update: Investigation of the Effects of a Multispecies Probiotic Formulation on Perennial Allergic Rhinitis [NA]
This clinical trial update indicates a multispecies probiotic formulation is being studied for perennial allergic rhinitis and is currently …
-
CLINICAL_TRIALS research · 2025-09-11Clinical Trial Update: Study to Evaluate the Efficacy and Safety of DW1807 in Perennial Allergic Rhinitis Patients With Asthma [Phase 3]
DW1807 is being studied in a Phase 3 trial for perennial allergic rhinitis with asthma, and the study is currently recruiting.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
EMA approval · 2025-06-27EMA Authorised: Avamys (fluticasone furoate) — GlaxoSmithKline Trading Services Limited
EMA has authorised Avamys (fluticasone furoate) nasal spray for allergic rhinitis, including seasonal and perennial forms.
-
FDA approval · 2025-04-17FDA Approved: CLARITIN CHEWABLE GRAPE AND BUBBLEGUM — Supplemental Application (Bayer HealthCare LLC.)
FDA approved a supplemental application to introduce Claritin Chewable Grape and Bubblegum (loratadine) by Bayer HealthCare LLC. This approv…
-
FDA approval · 2025-04-03FDA Approved: MONTELUKAST SODIUM — Supplemental Application (Torrent Pharmaceuticals Limited)
FDA approved Torrent Pharmaceuticals Limited's supplemental application for montelukast sodium (ANDA 201515), enabling the approval of a gen…
-
CLINICAL_TRIALS trial_result · 2024-09-19Clinical Trial Update: Efficacy and Safety of AM-301 on Allergic Symptoms of Perennial Allergic Rhinitis Sufferers [NA]
A completed clinical trial (NCT05122143) evaluated the efficacy and safety of AM-301 for allergic symptoms in perennial allergic rhinitis; r…
-
CLINICAL_TRIALS trial_result · 2024-08-29Clinical Trial Update: Efficacy/ Safety of Product CM9241GRU in Patients With Perennial Allergic Rhinitis [Phase 3]
This is a Phase 3 clinical trial evaluating the efficacy and safety of CM9241GRU in patients with perennial allergic rhinitis. The study is …
-
CLINICAL_TRIALS trial_result · 2024-08-15Clinical Trial Update: A Long-term Study of Mometasone Furoate in Patients With Perennial Allergic Rhinitis (Study P04459) [Phase 3]
A Phase 3 long-term study of mometasone furoate nasal spray in perennial allergic rhinitis has completed enrollment and status is listed as …
-
CLINICAL_TRIALS trial_result · 2024-08-15Clinical Trial Update: A Study of Mometasone Furoate Nasal Spray in Perennial Allergic Rhinitis (Study P03748)(COMPLETED) [Phase 2]
A Phase 2 clinical trial evaluating Mometasone Furoate Nasal Spray for perennial allergic rhinitis has completed.
-
CLINICAL_TRIALS trial_result · 2023-12-19Clinical Trial Update: Efficacy and Safety Evaluation for the Treatment of Asthma and Allergic Rhinitis/Rhinoconjunctivitis [Phase 3]
Phase 3 trial update evaluating efficacy and safety for allergic rhinitis/conjunctivitis; trial status terminated.
-
FDA approval · 2023-11-27FDA Approved: MONTELUKAST SODIUM — Supplemental Application (Dr.Reddy's Laboratories Limited)
The FDA approved a supplemental application for montelukast sodium from Dr. Reddy's Laboratories Limited, representing an additional approva…
-
FDA approval · 2023-11-21FDA Approved: MONTELUKAST SODIUM — Supplemental Application (Accord Healthcare Inc.)
FDA approves Accord Healthcare Inc.'s Montelukast Sodium supplemental application for the generic product, enabling its labeling and market …
-
FDA approval · 2023-10-02FDA Approved: MONTELUKAST SODIUM — Supplemental Application (Westminster Pharmaceuticals, LLC)
The FDA approved Westminster Pharmaceuticals, LLC's supplemental application for Montelukast Sodium, a generic product under an ANDA.
-
FDA approval · 2023-08-08FDA Approved: FLUTICASONE PROPIONATE — Supplemental Application (Padagis Israel Pharmaceuticals Ltd)
FDA approved a supplemental application for Fluticasone Propionate by Padagis Israel Pharmaceuticals Ltd, indicating an approved update to a…
-
FDA approval · 2023-06-28FDA Approved: MONTELUKAST SODIUM — Supplemental Application (Unichem Pharmaceuticals (USA), Inc.)
FDA approved a supplemental ANDA for Montelukast Sodium from Unichem Pharmaceuticals (USA), Inc., adding a generic Montelukast Sodium produc…
-
EMA approval · 2023-06-01EMA Authorised: Desloratadine Actavis (desloratadine) — Actavis Group PTC ehf
The EMA has authorised Desloratadine Actavis (desloratadine) for allergic rhinitis and urticaria indications in the European Union.
-
FDA approval · 2023-03-09FDA Approved: RUGBY MOMETASONE FUROATE NASAL — Supplemental Application (Rugby Laboratories)
FDA approved a supplemental application for Rugby Mometasone Furoate Nasal (mometasone furoate) submitted by Rugby Laboratories.
-
FDA approval · 2022-12-27FDA Approved: CHILDRENS ALLEGRA ALLERGY — Supplemental Application (Chattem, Inc.)
FDA approved a supplemental application for Children's Allegra Allergy containing fexofenadine hydrochloride, submitted by Chattem, Inc., to…
-
CLINICAL_TRIALS trial_result · 2022-11-18Clinical Trial Update: Efficacy and Safety Evaluation for the Treatment of HDM Induced Allergic Asthma and Rhinitis/Rhinoconjunctivitis [Phase 3]
Phase 3 clinical trial evaluating efficacy and safety for treatment of house dust mite–induced allergic asthma and perennial allergic rhinit…
-
CLINICAL_TRIALS trial_result · 2022-04-25Clinical Trial Update: A Study to Assess Efficacy and Safety of Nasacort® Nasal Spray in Comparison With Flixonase® Nasal Spray in Adults Suffering From Perennial Allergic Rhinitis (PAR) [Phase 3]
Phase 3 trial comparing Nasacort nasal spray to Flixonase in adults with perennial allergic rhinitis has completed.
-
CLINICAL_TRIALS trial_result · 2022-02-17Clinical Trial Update: Preference for Clarinex Tablets vs. Zyrtec Tablets in Patients With Allergies (P03180) [Phase 4]
Phase 4 trial comparing Clarinex tablets to Zyrtec tablets in patients with seasonal and perennial allergic rhinitis has completed.
-
CLINICAL_TRIALS trial_result · 2022-02-17Clinical Trial Update: Preference for Clarinex Tablets vs. Zyrtec Tablets in Patients With Allergies (P03182) [Phase 4]
Phase 4 trial update comparing Clarinex tablets to Zyrtec tablets in patients with seasonal and perennial allergic rhinitis.